# Corporate%20Governance
Latest news and articles about Corporate%20Governance
Total: 62 articles found
Transparency Crackdown: CSRC Targets LS Heavy Equipment in Disclosure Probe
The CSRC has launched an investigation into LS Heavy Equipment and its parent group for suspected information disclosure violations. While the company claims operations remain unaffected, the move reflects a tightening regulatory environment for Chinese listed firms and state-owned enterprises.
Silicon Giant Cracked: Hoshine’s Three-Billion-Yuan Loss Signals a Reckoning in China’s Green Supply Chain
Chinese silicon leader Hoshine Silicon reported a massive 2.99 billion RMB loss for 2025 due to plummeting material prices and asset impairments. The company is currently navigating regulatory sanctions for disclosure violations and is divesting loss-making chip assets to insiders to manage its rising debt.
Vanke’s Shadow Empire: How Onewo Executives Opaque Supplier Web Siphoned Wealth During a Property Crisis
Investigative reports reveal that Onewo executives utilized a complex network of offshore shadow companies to siphon billions from Vanke's property services arm via rigged supplier contracts and middleman acquisition deals. This systemic extraction occurred even as Vanke faced historic losses, exposing severe governance failures within one of China's most prominent real estate groups.
Xiaomi’s EV Moonshot Meets the Market’s Gravity
Xiaomi faces a severe valuation crisis as its EV delivery momentum slows and smartphone profit margins hit record lows. Despite massive share buybacks and the hiring of Tesla veterans, the company's shift toward high-margin appliances and centralized leadership reflects an urgent need to stabilize its core business to fund its automotive ambitions.
The Musk Ecosystem: How SpaceX and Internal Entities Bolstered Early Cybertruck Sales
Recent registration data shows that nearly 20% of Tesla Cybertruck sales in Q4 were driven by internal purchases from SpaceX and other Musk-led companies, totaling over $100 million in value.
Haier’s Fountain of Youth Nightmare: Appliance Giants and Fugitives in China’s High-End Health Scandal
A public legal battle between Haier Group and cosmetic mogul Yu Wenhong has unmasked a network of high-priced 'blood exchange' anti-aging clinics. The investigation reveals that the facility's operator is a former fugitive with a history of fraud, raising serious concerns over Haier's corporate due diligence and the lack of oversight in China's burgeoning concierge medicine industry.
Stretching Thin: Can China’s Middle Class Save Lululemon from a Toxicity Crisis?
Lululemon faces a critical trust crisis in China following a Texas-led investigation into toxic chemicals in its apparel. As the brand’s only remaining growth market, China’s response to these safety concerns and the rise of local 'dupe' brands poses a systemic threat to Lululemon's premium market position.
Cracks in the Foundation: China’s Easyhome Grapples with Financial Loss and Governance Chaos
Easyhome has reported its first annual loss in a decade, struggling with a nearly 1 billion RMB deficit and the sudden death of its founder following a corruption probe. The company's 'smart' digital transformation is faltering, while major merchant fraud scandals have severely damaged its brand reputation and ESG standing.
Unraveling the Fabric: Lululemon Faces a Health Crisis and a Stagnant West
Lululemon is navigating a multifaceted crisis involving a Texas investigation into toxic 'forever chemicals' in its clothing and a 13% drop in annual net profit. As North American sales stagnate, the brand is aggressively pivoting toward the Chinese market to sustain growth while facing internal criticism over its brand direction.
The Mogul and the Merchant: A Tale of Two Chinas and the New Moral Economy
The simultaneous sentencing of Evergrande’s Xu Jiayin and the rise of retail icon Yu Donglai signify a pivot in Chinese corporate values. This shift moves the focus from debt-driven real estate speculation toward a sustainable, employee-centric model that prioritizes trust and quality over raw growth.
Vintage Desperation: A Chinese Health Wine Pioneer’s Brinkmanship on the Trading Floor
Hainan Yedao, once China’s premier health wine brand, is facing a delisting crisis as auditors investigate suspicious revenue spikes and newly-formed shell companies acting as major distributors. The firm must prove it has legitimately crossed a 300-million-yuan revenue threshold or face expulsion from the Shanghai Stock Exchange.
Distilling Desperation: The Delisting Crisis Facing China’s 'First Health Wine' Brand
Hainan Yedao is facing potential delisting as auditors question the legitimacy of its 2025 revenue figures, which are propped up by suspicious late-year sales and newly registered distributors. The company's decline from an industry leader to a struggling shell entity highlights severe failures in governance and strategic focus.